Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
-
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
-
Canoo Inc. Announces First Quarter 2024 Results
-
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
-
RYVYL Reports Q1 2024 Results
-
Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
-
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
-
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
-
Pulse Biosciences Enhances Executive Leadership Team
-
Nasdaq Announces 2024 Annual Meeting of Shareholders
-
Rumble Reports First Quarter 2024 Results
-
Star Bulk Announces Date for the Release of First Quarter Ended March 31, 2024 Results, Conference Call and Webcast
-
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress
-
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
-
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
-
Fiverr to Present at Upcoming Conference
-
Iridex Reports First Quarter 2024 Financial Results
-
Jones Soda Reports First Quarter 2024 Results
-
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
-
MP Materials to Participate in TD Cowen 2nd Annual Sustainability Week
-
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
-
Robinhood Markets, Inc. to Present at the J.P. Morgan Global Technology, Media and Communications Conference on May 21, 2024
-
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
-
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
-
Nyxoah Reports First Quarter 2024 Financial and Operating Results
-
Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Wednesday, May 29, 2024
-
Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Sonim Reports 25% Sequential Increase in Revenue, Continues Advancement into New Addressable Markets
-
ParkerVision Reports First Quarter 2024 Results
-
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
-
Petco Health + Wellness Company, Inc. Announces Appointment of Glenn Murphy as Executive Chairman of the Board of Directors
-
Eos Energy Enterprises Reports First Quarter 2024 Financial Results and Announces Successful Completion of Factory Acceptance Testing
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
-
Conifer Holdings Reports 2024 First Quarter Financial Results
-
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
-
SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart
-
Aptose Reports Results for the First Quarter 2024
-
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
-
Superior Announces Record First Quarter Adjusted EBITDA of $235.6 Million, Adopts U.S. Dollar Reporting and Maintains 2024 Adjusted EBITDA Growth Expectations
-
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
-
Origin Materials, Inc. Reports Operating and Financial Results for First Quarter 2024
-
VSE Corporation Announces Public Offering of Common Stock
-
AN2 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business and Scientific Highlights
-
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
